Permitted Free Writing Prospectuses Clause Example from Business Contracts

This example Permitted Free Writing Prospectuses clause appears in 14 contracts from 11 companies

Permitted Free Writing Prospectuses. Each of the Company and the Agent represents, warrants and agrees that, unless it obtains the prior written consent of the other party, which consent shall not be unreasonably withheld, conditioned or delayed, it has not made and will not make any offer relating to the Placement Shares that would constitute an issuer free writing prospectus, or that would otherwise constitute a free writing prospectus (as defined in Rule 405), required to be filed with the Commission. Any such free writing prosp...ectus consented to by the Agent or by the Company, as the case may be, is hereinafter referred to as a "Permitted Free Writing Prospectus." The Company represents and warrants that it has treated and agrees that it will treat each Permitted Free Writing Prospectus as an issuer free writing prospectus, and that it has complied and will comply with the requirements of Rule 433 applicable to any Permitted Free Writing Prospectus, including timely filing with the Commission where required, legending and record keeping. View More Arrow
Found in VITAL THERAPIES INC contract
VITAL THERAPIES INC Contracts

Sales Agreement, dated as of July 17, 2019, between SVB Leerink LLC and Immunic, Inc (Filed With SEC on July 17, 2019)

Sales Agreement, dated as of December 29, 2020, between SVB Leerink LLC and Immunic, Inc (Filed With SEC on January 4, 2021)

Sales Agreement, dated as of May 2, 2022, between SVB Securities LLC and Immunic, Inc (Filed With SEC on May 2, 2022)

INSMED Inc Contracts

Sales Agreement, dated as of February 25 2021, between SVB Leerink LLC and Insmed Incorporated (Filed With SEC on February 25, 2021)

Evolus, Inc. Contracts

Sales Agreement, dated March 26, 2021, by and between Evolus, Inc. and SVB Leerink LLC as Sales Agent (Filed With SEC on March 26, 2021)

Dare Bioscience, Inc. Contracts

Sales Agreement, dated as of April (Filed With SEC on April 8, 2021)

Sales Agreement, dated as of (Filed With SEC on October 13, 2021)

EYENOVIA, INC. Contracts

Sales Agreement, dated as of May 14, 2021, between Eyenovia, Inc. and SVB Leerink LLC (Filed With SEC on May 14, 2021)

Athenex, Inc. Contracts

Sales Agreement, dated August 20, 2021, by and between the Company and SVB Leerink LLC as sales agent (Filed With SEC on August 20, 2021)

Eloxx Pharmaceuticals, Inc. Contracts

Sales Agreement, dated as of September 30, 2021, by and between Eloxx Pharmaceuticals, Inc. and SVB Leerink, LLC (Filed With SEC on September 30, 2021)

Tenaya Therapeutics, Inc. Contracts

Sales Agreement, dated as of August 10, 2022, between Tenaya Therapeutics, Inc. and SVB Securities LLC (Filed With SEC on August 10, 2022)

Entera Bio Ltd. Contracts

Sales Agreement, dated September 2, 2022, by and between Entera Bio Ltd. and SVB Securities LLC (Filed With SEC on September 2, 2022)

FS Development Corp. Contracts

Sales Agreement dated January 25, 2023 by and between Disc Medicine, Inc. and SVB Securities LLC (Filed With SEC on January 25, 2023)

Centessa Pharmaceuticals Ltd Contracts

Sales Agreement, dated January 27, 2023, by and between the Company and SVB Securities LLC (Filed With SEC on January 27, 2023)